Literature DB >> 27129207

Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation.

Joerg Schaarschmidt1, Marcus B M Nagel2, Sandra Huth1, Holger Jaeschke1, Rocco Moretti3, Vera Hintze4, Martin von Bergen5, Stefan Kalkhof6, Jens Meiler3, Ralf Paschke7.   

Abstract

The thyroid stimulating hormone receptor (TSHR) is a G protein-coupled receptor (GPCR) with a characteristic large extracellular domain (ECD). TSHR activation is initiated by binding of the hormone ligand TSH to the ECD. How the extracellular binding event triggers the conformational changes in the transmembrane domain (TMD) necessary for intracellular G protein activation is poorly understood. To gain insight in this process, the knowledge on the relative positioning of ECD and TMD and the conformation of the linker region at the interface of ECD and TMD are of particular importance. To generate a structural model for the TSHR we applied an integrated structural biology approach combining computational techniques with experimental data. Chemical cross-linking followed by mass spectrometry yielded 17 unique distance restraints within the ECD of the TSHR, its ligand TSH, and the hormone-receptor complex. These structural restraints generally confirm the expected binding mode of TSH to the ECD as well as the general fold of the domains and were used to guide homology modeling of the ECD. Functional characterization of TSHR mutants confirms the previously suggested close proximity of Ser-281 and Ile-486 within the TSHR. Rigidifying this contact permanently with a disulfide bridge disrupts ligand-induced receptor activation and indicates that rearrangement of the ECD/extracellular loop 1 (ECL1) interface is a critical step in receptor activation. The experimentally verified contact of Ser-281 (ECD) and Ile-486 (TMD) was subsequently utilized in docking homology models of the ECD and the TMD to create a full-length model of a glycoprotein hormone receptor.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein-coupled receptor (GPCR); cell signaling; computer modeling; mass spectrometry (MS); protein cross-linking; receptor structure-function; site-directed mutagenesis; structural biology; surface plasmon resonance (SPR)

Mesh:

Substances:

Year:  2016        PMID: 27129207      PMCID: PMC4933169          DOI: 10.1074/jbc.M115.709659

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function.

Authors:  H Jaeschke; S Neumann; G Kleinau; S Mueller; M Claus; G Krause; R Paschke
Journal:  Endocrinology       Date:  2006-01-12       Impact factor: 4.736

2.  Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.

Authors:  Paul Sanders; Stuart Young; Jane Sanders; Katarzyna Kabelis; Stuart Baker; Andrew Sullivan; Michele Evans; Jill Clark; Jane Wilmot; Xiaoling Hu; Emma Roberts; Michael Powell; Ricardo Núñez Miguel; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  J Mol Endocrinol       Date:  2011-02-15       Impact factor: 5.098

3.  Calibur: a tool for clustering large numbers of protein decoys.

Authors:  Shuai Cheng Li; Yen Kaow Ng
Journal:  BMC Bioinformatics       Date:  2010-01-13       Impact factor: 3.169

4.  A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR).

Authors:  Holger Jäschke; Susanne Neumann; Susanna Moore; Craig J Thomas; Anny-Odile Colson; Stefano Costanzi; Gunnar Kleinau; Jian-Kang Jiang; Ralf Paschke; Bruce M Raaka; Gerd Krause; Marvin C Gershengorn
Journal:  J Biol Chem       Date:  2006-02-16       Impact factor: 5.157

5.  Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation.

Authors:  Sandra Mueller; Gunnar Kleinau; Holger Jaeschke; Ralf Paschke; Gerd Krause
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

6.  Effects of mutations involving cysteine residues distal to the S281HCC motif at the C-terminus on the functional characteristics of a truncated ectodomain-only thyrotropin receptor anchored on glycosylphosphatidyl-inositol.

Authors:  Su-Chin Ho; Sui-Sin Goh; Sun Li; Daphne Hsu-Chin Khoo; Malcolm Paterson
Journal:  Thyroid       Date:  2008-12       Impact factor: 6.568

7.  A newly discovered TSHR variant (L665F) associated with nonautoimmune hyperthyroidism in an Austrian family induces constitutive TSHR activation by steric repulsion between TM1 and TM7.

Authors:  Holger Jaeschke; Joerg Schaarschmidt; Markus Eszlinger; Sandra Huth; Rudolf Puttinger; Olaf Rittinger; Jens Meiler; Ralf Paschke
Journal:  J Clin Endocrinol Metab       Date:  2014-06-20       Impact factor: 5.958

8.  Chances and pitfalls of chemical cross-linking with amine-reactive N-hydroxysuccinimide esters.

Authors:  Stefan Kalkhof; Andrea Sinz
Journal:  Anal Bioanal Chem       Date:  2008-09       Impact factor: 4.142

9.  Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity.

Authors:  T Braun; P R Schofield; R Sprengel
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

10.  Benchmarking and analysis of protein docking performance in Rosetta v3.2.

Authors:  Sidhartha Chaudhury; Monica Berrondo; Brian D Weitzner; Pravin Muthu; Hannah Bergman; Jeffrey J Gray
Journal:  PLoS One       Date:  2011-08-02       Impact factor: 3.240

View more
  6 in total

Review 1.  TSHR as a therapeutic target in Graves' disease.

Authors:  Terry Smith
Journal:  Expert Opin Ther Targets       Date:  2017-02-06       Impact factor: 6.902

2.  TSH Receptor Signaling Abrogation by a Novel Small Molecule.

Authors:  Rauf Latif; Ronald B Realubit; Charles Karan; Mihaly Mezei; Terry F Davies
Journal:  Front Endocrinol (Lausanne)       Date:  2016-09-27       Impact factor: 5.555

Review 3.  Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease.

Authors:  Hidefumi Inaba; Leslie J De Groot; Takashi Akamizu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-23       Impact factor: 5.555

4.  Structure and activation of the TSH receptor transmembrane domain.

Authors:  Ricardo Núñez Miguel; Jane Sanders; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2016-12-05

Review 5.  Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.

Authors:  Gunnar Kleinau; Catherine L Worth; Annika Kreuchwig; Heike Biebermann; Patrick Marcinkowski; Patrick Scheerer; Gerd Krause
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

6.  A Gq Biased Small Molecule Active at the TSH Receptor.

Authors:  Rauf Latif; Syed A Morshed; Risheng Ma; Bengu Tokat; Mihaly Mezei; Terry F Davies
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-26       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.